Biomaterials maker Origin Q3 revenue falls on reduction in the supply chain activation program

Origin Materials

13/11/2025 21:18

Overview

Origin Materials Q3 revenue fell to $4.7 mln, down from $8.2 mln last year

Company secures convertible debt financing up to $90 mln to fund growth

Origin announces $20 mln equipment financing, increasing CapFormer capacity

Outlook

Origin Materials maintains 2026 revenue guidance of $20 mln to $30 mln

Company expects 2027 revenue of $100 mln to $200 mln

Origin anticipates Adjusted EBITDA run-rate breakeven by 2027

Result Drivers

FINANCING - Origin secures convertible debt financing up to $90 mln to maintain cash floor and fund growth

CUSTOMER DEMAND - Strong demand for PET caps, particularly in water segment, supports commercialization strategy

CAPFORMER EXPANSION - CapFormer deployment schedule on track, supporting revenue growth strategy

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
$4.66 mln
Q3 EPS
-$0.11
Q3 Net Income
-$16.38 mln
Q3 Adjusted EBITDA
-$11.60 mln
Q3 Operating Expenses
$17.09 mln


Analyst Coverage

The one available analyst rating on the shares is "buy"

The average consensus recommendation for the commodity chemicals peer group is "buy"

Wall Street's median 12-month price target for Origin Materials Inc is $2.00, about 74.6% above its November 12 closing price of $0.51

Press Release: ID:nBwblKQFGa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)